MRI

SimonMed Expands AI-Enhanced MRI with SwiftMR Deployment

SimonMed has deployed AIRS Medical’s AI-powered SwiftMR solution across its nationwide imaging network to improve MRI image quality, reduce scan times, and support workflow efficiency across a multi-vendor MRI infrastructure.

Combined OCT and MRI Improve Diagnosis of MINOCA

A dual imaging approach combining OCT and cardiac MRI identified the underlying cause in 79% of patients with myocardial infarction and non-obstructive coronary arteries (MINOCA).

MRI Combination Marker Shows High Accuracy in Cervical Cancer Grading

Combining diffusion MRI parameters with macromolecular proton fraction (MPF) achieved a 96% AUC in differentiating low- and high-grade cervical cancer.

Premier Radiology Expands Teleradiology with GLOBIS Acquisition

The acquisition is intended to strengthen diagnostic imaging coverage and support growing demand for outpatient imaging services.

Japan Approves Low-Dose MRI Contrast Agent Ambelvist

Bayer has received the first global approval for its low-dose MRI contrast agent Ambelvist™ (gadoquatrane) in Japan.

Bracco at ECR: AI, contrast agents and new paths to more precise imaging

Bracco Imaging showcased AiMIFY® at ECR, an AI-powered MRI contrast enhancement solution developed with Subtle Medical that analyzes brain scans and amplifies existing contrast signals.

UChicago Medicine Expands Neurosurgery With Intraoperative MRI

UChicago Medicine has introduced intraoperative MRI technology to support complex neurosurgical procedures, enabling real-time imaging during surgery and enhancing precision, safety, and workflow efficiency.

Siemens Healthineers Showcases Imaging Innovations at RSNA 2025

New systems aim to improve lesion visibility, workflow efficiency, and interventional imaging capabilities

Esaote Unveiled New Ultrasound Systems and AI Imaging Tools at ECR 2026

Italian imaging specialist introduced new ultrasound platforms for interventional radiology alongside AI-powered MRI and enterprise imaging innovations.

Bayer Presents New Data for Contrast Agent Gadoquatrane from Phase III Program at ECR 2026

New analyses show Bayer’s investigational MRI contrast agent delivers non-inferior diagnostic performance while reducing gadolinium dose by 60%.

Prof. Minerva Becker on Imaging, AI and the Vision Behind ECR 2026

In our interview, ECR 2026 President Prof. Minerva Becker shares her vision for “Rays of Knowledge,” education, AI and the future of imaging.

Imaging risks for the most vulnerable patients

Possibilities to improve imaging and reduce exposure

Bayer Presents Phase III Cardiac MRI Data for Low-Dose Gadoquatrane

Bayer has reported positive Phase III subgroup data for its investigational low-dose MRI contrast agent gadoquatrane in cardiac MRI. The results, presented at SCMR 2026, support efficacy and safety with a 60% reduction in gadolinium dose compared to standard macrocyclic agents.

Guerbet Highlights Centenary and Imaging Portfolio at ECR 2026

At ECR 2026 in Vienna, Guerbet will mark its 100th anniversary while presenting developments across contrast-enhanced MRI, real-world evidence, and international collaboration

Bayer to Present Phase III Gadoquatrane Data at ECR 2026

Bayer will present new Phase III clinical data for its investigational low-dose MRI contrast agent gadoquatrane at ECR 2026 in Vienna.

NHS Fife Cuts MRI Scan Times Over 20% With Siemens AI

NHS Fife has implemented Siemens Healthineers’ Deep Resolve technology to shorten MRI scan times by more than 20%. The AI-based image reconstruction approach has reduced waiting times, and enabled nearly 1,900 additional MRI appointments within six months.

MRI Connectivity Patterns May Help Predict TBI Recovery

New research suggests that resting-state functional MRI performed shortly after traumatic brain injury may help predict long-term recovery. Specific brain connectivity patterns were found to be associated with functional outcomes six months after injury.

ASE Reviews 2025 Advocacy Priorities in Cardiovascular Imaging

The American Society of Echocardiography (ASE) has reviewed its healthcare advocacy activities in 2025, highlighting efforts related to Medicare reimbursement, workforce shortages, artificial intelligence policy, and federal research funding in cardiovascular imaging.

ESR Welcomes EU Safe Hearts Plan for Cardiovascular Health

The European Society of Radiology (ESR) has welcomed the European Commission’s Safe Hearts Plan, a new EU-wide strategy to address cardiovascular health in Europe.

Bayer Reports Positive Pediatric Data for Low-Dose MRI Contrast Agent Gadoquatrane

Bayer has released late-breaking results from the QUANTI Pediatric study, showing that its investigational low-dose MRI contrast agent gadoquatrane met all primary and secondary endpoints in children.

Expanding Evidence in Pediatric MRI: Bayer Highlights at RSNA

Advancing patient-centered imaging through pediatric data, contrast innovation, and cross-disciplinary collaboration

RSNA 2025: Imaging the Hidden Language of the Brain

A session highlighting how amyloid, tau, and FDG PET sharpen Alzheimer’s diagnosis, support therapy decisions, and improve safety monitoring, marking a key advance in precision imaging.

Innovating Cancer Care: Bayer’s Low-Dose Contrast Enhanced MRI

Advancing radiology for smart imaging

Circular MRI Model Could Save Hospitals Over $500K Per Scanner

Adopting circular business models for MRI systems could reduce total ownership costs by up to 21% and cut emissions and material use significantly.

Transforming Prostate Care: Innovation and Progress through Partnership in Radiology

Two leading voices discuss how collaboration drives progress in oncologic imaging.

Digital Twins in Radiology: Your Key Questions Answered

Learn what digital twins mean for CT and MRI – from workflow optimization to ROI – in this industry-focused radiology FAQ.

Radiology Staffing Shortages: U.S. vs. UK Approaches

High vacancy rates continue to affect imaging departments. Data highlights the scale of the workforce shortage and measures to address the challenge.

FDA Grants Clearance for DeepHealth’s TechLive™

DeepHealth has received FDA 510(k) clearance for TechLive™, a vendor-agnostic remote scanning solution.

Neuroradiology Enables Targeted Treatment for Pulse-Synchronous Tinnitus

Advances in imaging techniques improve diagnosis and therapy options for vascular-related tinnitus symptoms

Bayer files for EU approval of gadoquatrane

Submitted dose corresponds to 60% gadolinium reduction compared to standard macrocyclic agents

AI-QUAL: First AI Module for Automated Prostate MRI Quality Scoring

Quibim launches AI-QUAL to standardize prostate MRI quality assessment and support more accurate prostate cancer diagnostics

Bayer Submits MRI Contrast Agent Gadoquatrane for FDA Review

If approved, gadoquatrane would become the lowest-dose macrocyclic gadolinium-based contrast agent available in the U.S. market.

Röko 2025: mediaire Demonstrates AI for Prostate Diagnostics

AI Supports Full Patient Journey and Fusion Biopsy

RöKo 2025: AIRS Medical Showcases AI Innovation in MRI

Improving MRI Efficiency and Image Quality with AI-Based Solution

Siemens Healthineers Presents MAGNETOM Flow RT Pro Edition for Sustainable Magnetic Resonance Imaging in Radiation Therapy

Siemens Healthineers showcased its latest MRI system for radiation therapy at this year’s European Society for Radiotherapy and Oncology congress.

Shedding Light on the Invisible: Opening of the RöKo 2025

What can radiology do today - and what will it be capable of tomorrow?